Tumor Immunity Therapy and Forecast Market

List of Tables
Table 1. Tumor Immunity Therapy Market Opportunities & Trends in Global Market
Table 2. Tumor Immunity Therapy Market Drivers in Global Market
Table 3. Tumor Immunity Therapy Market Restraints in Global Market
Table 4. Key Players of Tumor Immunity Therapy in Global Market
Table 5. Top Tumor Immunity Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Tumor Immunity Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Tumor Immunity Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Tumor Immunity Therapy Product Type
Table 9. List of Global Tier 1 Tumor Immunity Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Immunity Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tumor Immunity Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Tumor Immunity Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Tumor Immunity Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Tumor Immunity Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Tumor Immunity Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Tumor Immunity Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Tumor Immunity Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Tumor Immunity Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Tumor Immunity Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Tumor Immunity Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Tumor Immunity Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Tumor Immunity Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Tumor Immunity Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Tumor Immunity Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Bristol-Myers Squibb Company Summary
Table 31. Bristol-Myers Squibb Tumor Immunity Therapy Product Offerings
Table 32. Bristol-Myers Squibb Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Bristol-Myers Squibb Key News & Latest Developments
Table 34. Merck & Co., Inc. Company Summary
Table 35. Merck & Co., Inc. Tumor Immunity Therapy Product Offerings
Table 36. Merck & Co., Inc. Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Merck & Co., Inc. Key News & Latest Developments
Table 38. Roche AG Company Summary
Table 39. Roche AG Tumor Immunity Therapy Product Offerings
Table 40. Roche AG Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Roche AG Key News & Latest Developments
Table 42. AstraZeneca, Plc Company Summary
Table 43. AstraZeneca, Plc Tumor Immunity Therapy Product Offerings
Table 44. AstraZeneca, Plc Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca, Plc Key News & Latest Developments
Table 46. Sanofi S.A. Company Summary
Table 47. Sanofi S.A. Tumor Immunity Therapy Product Offerings
Table 48. Sanofi S.A. Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi S.A. Key News & Latest Developments
Table 50. Dendreon Pharmaceuticals Company Summary
Table 51. Dendreon Pharmaceuticals Tumor Immunity Therapy Product Offerings
Table 52. Dendreon Pharmaceuticals Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Dendreon Pharmaceuticals Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Tumor Immunity Therapy Product Offerings
Table 56. Novartis Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Gilead Sciences Inc. Company Summary
Table 59. Gilead Sciences Inc. Tumor Immunity Therapy Product Offerings
Table 60. Gilead Sciences Inc. Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Gilead Sciences Inc. Key News & Latest Developments
Table 62. IMVAQ Therapeutics Company Summary
Table 63. IMVAQ Therapeutics Tumor Immunity Therapy Product Offerings
Table 64. IMVAQ Therapeutics Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. IMVAQ Therapeutics Key News & Latest Developments
Table 66. Arch Oncology Company Summary
Table 67. Arch Oncology Tumor Immunity Therapy Product Offerings
Table 68. Arch Oncology Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Arch Oncology Key News & Latest Developments
Table 70. Juno Therapeutics Company Summary
Table 71. Juno Therapeutics Tumor Immunity Therapy Product Offerings
Table 72. Juno Therapeutics Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Juno Therapeutics Key News & Latest Developments
Table 74. Refuge Company Summary
Table 75. Refuge Tumor Immunity Therapy Product Offerings
Table 76. Refuge Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Refuge Key News & Latest Developments
Table 78. Lepu Biopharma Company Summary
Table 79. Lepu Biopharma Tumor Immunity Therapy Product Offerings
Table 80. Lepu Biopharma Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Lepu Biopharma Key News & Latest Developments
Table 82. Genoimmune Company Summary
Table 83. Genoimmune Tumor Immunity Therapy Product Offerings
Table 84. Genoimmune Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Genoimmune Key News & Latest Developments
Table 86. TCR Cure Company Summary
Table 87. TCR Cure Tumor Immunity Therapy Product Offerings
Table 88. TCR Cure Tumor Immunity Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. TCR Cure Key News & Latest Developments
List of Figures
Figure 1. Tumor Immunity Therapy Segment by Type in 2022
Figure 2. Tumor Immunity Therapy Segment by Application in 2022
Figure 3. Global Tumor Immunity Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tumor Immunity Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Tumor Immunity Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tumor Immunity Therapy Revenue in 2022
Figure 8. By Type - Global Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Tumor Immunity Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Tumor Immunity Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 16. US Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 28. China Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Tumor Immunity Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Tumor Immunity Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Bristol-Myers Squibb Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck & Co., Inc. Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche AG Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca, Plc Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi S.A. Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Dendreon Pharmaceuticals Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Gilead Sciences Inc. Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. IMVAQ Therapeutics Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Arch Oncology Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Juno Therapeutics Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Refuge Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Lepu Biopharma Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Genoimmune Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. TCR Cure Tumor Immunity Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)